4 Stocks To Buy And Sell Now

by: David Ristau

By Joey Vazquez, Oxen Group Contributor

We continue our search for the most attractive companies to buy and sell right now. We started the day on a slow foot as Spain's 10-year bond yield hit a record high but have since rallied on renewed hopes for stimulus. Today, I strive to find attractive companies with strong or weak fundamentals and technicals that will outperform or underperform the markets. Should you buy or sell these companies?

Boeing Co. (NYSE:BA):

(Click to enlarge)

Unknown ObjectBoeing has received various upgrades within the last month, including one from Stifel Financial Corp. (NYSE:SF) upgrading BA to Buy from Hold and raising their price target to $80. Just this morning, BA CEO Jim Albaugh told Reuters that BA is targeting 1,000 plane orders for the year, up from 921 in 2011. The markets have rewarded BA as it bottomed around $68, and BA bounced off its Bollinger Band to re-take its 200-day MA. BA also retook its middle price channel and its stochastics are also headed higher. Its MACD indicator has crossed its signal line, indicating the start of a new bullish trend.

Trade Idea: Go Long BA

  • Entry Range: 72.10-72.45
  • Targets: 72.97, 73.70
  • Stop loss: 70.80
  • Our Entry: 72.25

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN):

(Click to enlarge)

Alexion has been one of the few blue chips for 2012, already up over 30% for the year. ALXN was rewarded today for their strong success this year by TheStreet, as they reiterated ALXN as a Buy. Some of the strengths pointed out were; reasonable debt levels, notable ROE and impressive record of EPS growth. We have been a fan of ALXN all year after a recent FDA approval that should spark a lot of growth for the company. ALXN recently retook its pivot point, 20day and 50 day MA, which has caused a mini golden cross to form on its chart giving us a bullish indicator. The 20 and 50 day MA are also sitting right below the current stock price giving us very good support. ALXN OBV indicator is in a very strong upwards channel, showing the strong positive momentum is still increasing in the stock. The entire pharmaceutical sector looks fairly undervalued right now, and we like the looks of Onyx (NASDAQ:ONXX) as well for a breakout. Healthcare could be very strong place to be in second half of 2012.

Trade Idea: Go long ALXN

  • Entry Range: 92.57-92.99
  • Targets: 93.70, 94.63
  • Stop loss: 90.91
  • Our Entry: 92.77

Invesco Ltd. (NYSE:IVZ):

(Click to enlarge)

Invesco has been very weak since the beginning of May and there's no turnaround in sight. To add to IVZ worries, BMO Capital Markets downgraded IVZ today. IVZ also reported today that their assets under management decreased by $36.3B or 5.43% from last month. Asset management firms have been struggling as of late especially ones that seem to be more attune to low-risk investing. Many individuals seem to be leaving the market. Companies like IVZ and T.Rowe Price (NASDAQ:TROW) and Principal Financial (NYSE:PFG) are going to struggle. If we analyze its chart IVZ hit the resistance of its top BB and shot back down today. IVZ broke down through its 20 day MA today and as a result its stochastics have turned and are headed lower. IVZ OBV indicator has been on a strong decline since the beginning of May, illustrating the weakness in the stock.

Trade Idea: Go short IVZ

  • Entry Range: 21.67 - 21.78
  • Targets: 21.51, 21.30
  • Stop loss: 22.16
  • Our Entry: 21.73

DeVry Inc. (DV):

(Click to enlarge)

Devry has been one of the biggest laggards for the year, already down over 25% for the year and has been making new lows for the last three months. DV slightly beat their second quarter earnings, but this wasn't enough to impress investors. DV will continue to struggle along with the remaining institutions that have a large focus on online classes. The job market has turned up somewhat, which has drawn away going back to school. The government, additionally, has put a real black eye on for-profit education. We would be looking at shorting these companies as well as Apollo Group Inc. (NASDAQ:APOL) and Career Education Corp. (NASDAQ:CECO). DV recently tried to retake its 20 day MA and pivot point, but they held their ground and shot DV back down. DV now has very strong resistance from its 20 day MA and pivot point and as a result of its failed rally its stochastics have turned and are headed lower. DV OBV indicator is headed lower each day, showing very little positive momentum left.

Trade Idea: Go short DV

  • Entry Range: 27.30- 27.44
  • Targets: 27.12, 26.84
  • Stop loss: 27.94
  • Our Entry: 27.39

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.